Literature DB >> 8892759

Molecular cloning of the mouse apolipoprotein D gene and its upregulated expression in Niemann-Pick disease type C mouse model.

K Yoshida1, E S Cleaveland, J W Nagle, S French, L Yaswen, T Ohshima, R O Brady, P G Pentchev, A B Kulkarni.   

Abstract

Apolipoprotein D (ApoD) is a member of the lipocalin superfamily. The primary structure and diverse expression of ApoD suggest that this protein is a multiligand, multifunctional glycoprotein. Here we report the structure of the mouse ApoD gene, which is composed of six exons spanning approximately 20 kb in length. All the exon-intron splice junctions follow the consensus GT/AG sequence. The 5'-flanking region of the mouse ApoD gene contains several putative regulatory elements, including FSE-2, GRE, SDR, MRE, IL-6RE, and TATA box. Northern blot analysis revealed that ApoD was highly expressed in the brain and adipose tissue in mouse. Lower levels of expression were observed in the heart, lung, thymus, testis, and salivary glands. In situ hybridization for the brain showed that ApoD mRNA was mainly localized in the subarachnoid space including the pia. In the Niemann-Pick disease type C mouse model, ApoD expression was upregulated in many organs such as brain, adipose tissue, heart, and thymus, presumably due to enhanced ApoD synthesis in perivascular fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892759     DOI: 10.1089/dna.1996.15.873

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  11 in total

1.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

Review 3.  Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2013-01-05       Impact factor: 3.240

4.  Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.

Authors:  T Ohshima; M Ogawa; M Hirasawa; G Longenecker; K Ishiguro; H C Pant; R O Brady; A B Kulkarni; K Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 5.  The neurobiology of apolipoproteins in psychiatric disorders.

Authors:  J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

6.  Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous.

Authors:  T Ohshima; E C Gilmore; G Longenecker; D M Jacobowitz; R O Brady; K Herrup; A B Kulkarni
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

7.  Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development.

Authors:  Guanghong Liao; Zhining Wen; Kristopher Irizarry; Ying Huang; Katherine Mitsouras; Mariam Darmani; Terry Leon; Leming Shi; Xiaoning Bi
Journal:  Brain Res       Date:  2010-02-12       Impact factor: 3.252

8.  Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1-/- mice.

Authors:  Min Zhang; Diana Strnatka; Carolyn Donohue; Janice L Hallows; Inez Vincent; Robert P Erickson
Journal:  J Neurosci Res       Date:  2008-10       Impact factor: 4.164

9.  Amelioration of enteric neuropathology in a mouse model of Niemann-Pick C by Npc1 expression in enteric glia.

Authors:  Raj Kapur; Carolyn Donohue; David Jelinek; Robert P Erickson
Journal:  J Neurosci Res       Date:  2009-10       Impact factor: 4.164

10.  Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice.

Authors:  Ouafa Najyb; Sonia Do Carmo; Azadeh Alikashani; Eric Rassart
Journal:  Mol Neurobiol       Date:  2016-06-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.